Entresto 49 MG-51 MG tablet 180S
Ended Awarded Last action
- Contract number
- SPE2DR26FCX9H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,041
Award facts
- Contract value 100% obligated
- $41,040.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,040.97 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 6, 2026, for the supply of Entresto 49 mg-51 mg tablets (180-count packages). The contract is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through full and open competition. Performance will be executed at the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 7, 2026. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) vehicle between DLA Troop Support Medical and the contractor's parent company, Cencora, Inc. (doing business as AmerisourceBergen), valued at up to $999,999,999.00 through December 2031.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving critical medical procurement needs for the Department of Defense and military healthcare systems. The company supplies a comprehensive range of pharmaceutical products across multiple therapeutic domains through its relationship with DLA, which manages the federal medical supply chain. This particular order for Entresto, a cardiac medication, reflects the contractor's role in supporting military treatment facilities and defense health operations. As a non-set-aside competitive award, this delivery order demonstrates AmerisourceBergen's capability to meet federal procurement standards within the broader pharmaceutical supply vehicle administered by DLA Troop Support.
Quick answers
Who was awarded contract SPE2DR26FCX9H?
SPE2DR26FCX9H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FCX9H worth?
The government has obligated $41,041 on SPE2DR26FCX9H.
Is contract SPE2DR26FCX9H an order under another contract?
Yes. SPE2DR26FCX9H is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCX9H competed?
The extent of competition for SPE2DR26FCX9H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award